Total serum DNA and DNA integrity: Diagnostic value in patients with hepatitis B virus-related hepatocellular carcinoma

Pathology

Volumn 44, Issue 4, 2012, Pages 318-324

  Chen, Hui ^a   Sun, Ling Yu ^a   Zheng, Hong Qun ^a   Zhang, Qi Fan ^a   Jin, Xiao Ming ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Circulating DNA; DNA integrity; HCC; Real time PCR; Serum

Indexed keywords

EID: 84863648633     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0b013e328353a24c     Document Type: Article

References (45)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108. (Pubitemid 40372904)
2. Pisani P, Parkin DM, Munoz N, et al. Cancer and infection: estimates of the attributable fraction in 1990. Cancer Epidemiol Biomarkers Prev 1997; 6: 387-400. (Pubitemid 27270542)
3. Benson AB 3rd, Abrams TA, Ben-Josef E, et al. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw 2009; 7: 350-91.
4. Mandel P, Metais P. Les acides nucleiques du plasma sanquin chez I'homme. CR Acad Sci Paris 1948; 142: 241-3.
5. Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer - a survey. Biochim Biophys Acta 2007; 1775: 181-232. (Pubitemid 44911084)
6. Anker P, Mulcahy H, Chen XQ, et al. Detection of circulating tumour DNA in the blood (plasma/serum) of cancer patients. Cancer Metastasis Rev 1999; 18: 65-73. (Pubitemid 29411092)
7. Ziegler A, Zangemeister-Wittke U, Stahel RA. Circulating DNA: a new diagnostic gold mine? Cancer Treat Rev 2002; 28: 255-71. (Pubitemid 35439439)
8. Wang BG, Huang HY, Chen YC, et al. Increased plasma DNA integrity in cancer patients. Cancer Res 2003; 63: 3966-8. (Pubitemid 36917913)
9. Giacona MB, Ruben GC, Iczkowski KA, et al. Cell-free DNA in human blood plasma: Length measurements in patients with pancreatic cancer and healthy controls. Pancreas 1998; 17: 89-97. (Pubitemid 28293013)
10. Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biol Ther 2005; 4: 139-63. (Pubitemid 41351311)
11. Leon SA, Shapiro B, Sklaroff DM, et al. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 1977; 37: 646-50. (Pubitemid 8051621)
12. Silva JM, Garcia JM, Dominguez G, et al. Persistence of tumor DNA in plasma of breast cancer patients after mastectomy. Ann Surg Oncol 2002; 9: 71-6. (Pubitemid 34262900)
13. Fournié GJ, Courtin JP, Laval F, et al. Plasma DNA as a marker of cancerous cell death. Investigations in patients suffering from lung cancer and in nude mice bearing human tumours. Cancer Lett 1995; 91: 221-7.
14. Sozzi G, Conte D, Mariani L, et al. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Res 2001; 61: 4675-8. (Pubitemid 32691874)
15. Jung K, Stephan C, Lewandowski M, et al. Increased cell-free DNA in plasma of patients with metastatic spread in prostate cancer. Cancer Lett 2004; 205: 173-80. (Pubitemid 38230124)
16. Chang HW, Lee SM, Goodman SN, et al. Assessment of plasma DNA levels, allelic imbalance, and CA 125 as diagnostic tests for cancer. J Natl Cancer Inst 2002; 94: 1697-703. (Pubitemid 35446838)
17. Sozzi G, Conte D, Leon M, et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 2003; 21: 3902-8. (Pubitemid 46606202)
18. Gautschi O, Bigosch C, Huegli B, et al. Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy. J Clin Oncol 2004; 22: 4157-64. (Pubitemid 41185186)
19. Jahr S, Hentze H, Englisch S, et al. DNA fragments in the blood plasma of cancer patients: quantitations and evidence for their origin from apoptotic and necrotic cells. Cancer Res 2001; 61: 1659-65. (Pubitemid 34292602)
20. th ed. New York: Wiley, 2002; 131-41.
21. Fong SL, Zhang JT, Lim CK, et al. Comparison of 7 methods for extracting cell-free DNA from serum samples of colorectal cancer patients. Clin Chem 2009; 55: 587-9.
22. Xue X, Teare MD, Holen I, et al. Optimizing the yield and utility of circulating cell-free DNA from plasma and serum. Clin Chim Acta 2009; 404: 100-4.
23. Gal S, Fidler C, Lo YM, et al. Quantitation of circulating DNA in the serum of breast cancer patients by real-time PCR. Br J Cancer 2004; 90: 1211-5. (Pubitemid 38496815)
24. Cheng C, Omura-Minamisawa M, Kang Y, et al. Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapy. Cancer Sci 2009; 100: 303-9.
25. Thijssen MA, Swinkels DW, Ruers TJ, et al. Difference between free circulating plasma and serum DNA in patients with colorectal liver metastases. Anticancer Res 2002; 22: 421-5. (Pubitemid 34475333)
26. Llovet JM. Updated treatment approach to hepatocellular carcinoma. J Gastroenterol 2005; 40: 225-35. (Pubitemid 40613379)
27. Wagner PD, Verma M, Srivastava S. Challenges for biomarkers in cancer detection. Ann NY Acad Sci 2004; 1022: 9-16. (Pubitemid 38951575)
28. Umetani N, Hiramatsu S, Hoon DS. Higher amount of free circulating DNA in serum than in plasma is not mainly caused by contaminated extraneous DNA during separation. Ann NY Acad Sci 2006; 1075: 299-307. (Pubitemid 44532797)
29. Chiu RW, Poon LL, Lau TK, et al. Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem 2001; 47: 1607-13. (Pubitemid 32781573)
30. Swinkels DW, Wiegerinck E, Steegers EA, et al. Effects of blood-processing protocols on cell-free DNA quantification in plasma. Clin Chem 2003; 49: 525-6. (Pubitemid 36250226)
31. de Kok JB, Hendriks JC, van Solinge WW, et al. Use of real-time quantitative PCR to compare DNA isolation methods. Clin Chem 1998; 44: 2201-4. (Pubitemid 28447074)
32. Lee TH, Montalvo L, Chrebtow V, et al. Quantitation of genomic DNA in plasma and serum samples: higher concentrations of genomic DNA found in serum than in plasma. Transfusion 2001; 41: 276-82. (Pubitemid 32220522)
33. Lui YY, Chik KW, Chiu RW, et al. Predominant hematopoietic origin of cell-free DNA in plasma and serum after sex-mismatched bone marrow transplantation. Clin Chem 2002; 48: 421-7. (Pubitemid 34174575)
34. Herrera LJ, Raja S, Gooding WE, et al. Quantitative analysis of circulating plasma DNA as a tumor marker in thoracic malignancies. Clin Chem 2005; 51: 113-8. (Pubitemid 40024019)
35. Huang Z, Hua D, Hu Y, et al. Quantitation of plasma circulating DNA using quantitative PCR for the detection of hepatocellular carcinoma. Pathol Oncol Res 2012; 18: 271-6.
36. Ren N, Qin LX, Tu H, et al. The prognostic value of circulating plasma DNA level and its allelic imbalance on chromosome 8p in patients with hepatocellular carcinoma. J Cancer Res Clin Oncol 2006; 132: 399-407.
37. Chiu TW, Young R, Chan LY, et al. Plasma cell-free DNA as an indicator of severity of injury in burn patients. Clin Chem Lab Med 2006; 44: 13-7. (Pubitemid 43010638)
38. Zeerleder S, Zwart B, Wuillemin WA, et al. Elevated nucleosome levels in systemic inflammation and sepsis. Crit Care Med 2003; 31: 1947-51. (Pubitemid 36900748)
39. Lam NY, Rainer TH, Chan LY, et al. Time course of early and late changes in plasma DNA in trauma patients. Clin Chem 2003; 49: 1286-91. (Pubitemid 36900614)
40. Lam NY, Rainer TH, Wong LK, et al. Plasma DNA as a prognostic marker for stroke patients with negative neuroimaging within the first 24 h of symptom onset. Resuscitation 2006; 68: 71-8. (Pubitemid 43053370)
41. Rainer TH, Lam NY, Man CY, et al. Plasma beta-globin DNA as a prognosticmarker in chest pain patients. Clin Chim Acta 2006; 368: 110-3. (Pubitemid 43776038)
42. Holdenrieder S, Eichhorn P, Beuers U, et al. Nucleosomal DNA fragments in autoimmune diseases. Ann NY Acad Sci 2006; 1075: 318-27. (Pubitemid 44532800)
43. Shapiro B, Chakrabarty M, Cohn EM, et al. Determination of circulating DNA levels in patients with benign or malignant gastrointestinal disease. Cancer 1983; 51: 2116-20. (Pubitemid 13092467)
44. Holdenrieder S, Stieber P, Bodenmüller H, et al. Nucleosomes in serum of patients with benign and malignant diseases. Int J Cancer 2001; 95: 114-20. (Pubitemid 32187083)
45. Umetani N, Giuliano AE, Hiramatsu SH, et al. Prediction of breast tumor progression by integrity of free circulating DNA in serum. J Clin Oncol 2006; 24: 4270-6. (Pubitemid 46630784)